Baltimore, MD, May 6-8, 2010

Abstracts

Accepted Poster Abstracts, F-J

Presenting Author

Poster #

Abstract ID #

Mildred Farmer 164 215
Effect of adding milnacipran to pregabalin in the management of fibromyalgia: a randomized, open-label, controlled study
Sherin Fetouh 302 174
The significance of percutaneous aspiration of the zygapophysial facet joint synovial cyst: a case series
Magne Arve Flaten 321 214
Event-related potentials to painful stimulation after caffeine and placebo in a balanced placebo design
Alison Fleming 272 202
Steady-state pharmacokinetics of a novel, multiparticulate, extended-release formulation of oxycodone with tamper-resistant properties
Gonzalo Flores 213 248
Endogenous agmatine contributes to percutaneous electrical nerve stimulation evoked anti-allodynia
Stacy Flowers 161 234
The relationship between pain catastrophizing, coping efficacy and objectively measured physical activity in adolescents with Juvenile Primary Fibromyalgia Syndrome
John Fort 260 51
Analgesic doses of aspirin (ASA) cause significant upper gastrointestinal (UGI) damage: PA65020, a new combination of enteric-coated aspirin (EC-ASA) & immediate-release (IR) omeprazole significantly reduces the incidence of gastroduodenal ulcers (GU/DU)
Kimberly Fraser 251 92
Treating fibromyalgia with duloxetine among elderly patients: what is the association between average daily dose, medication adherence, and healthcare costs?
Kimberly Fraser 252 93
Medication adherence and healthcare costs among elderly fibromyalgia patients treated with duloxetine
Kimberly Fraser 253 94
An assessment of treatment patterns and healthcare costs among working-aged individuals initiated with duloxetine for fibromyalgia
Kimberly Fraser 254 96
Duloxetone treatment patterns and healthcare costs among fibromyalgia patients with medicare supplemental insurance
Arnold Gammaitoni 137 106
Response to NSAIDs or placebo in osteoarthritis is primarily determined within the first week of treatment.
Michael Geisser 163 199
Improvements in pain associated with fibromyalgia: results from 3 clinical trials of milnacipran
F. Michael Gloth 306 252
Safety of diclofenac sodium 1% gel for knee osteoarthritis in patients with comorbidities
Kellee Gooden 229 299
Topical menthol and capsaicin for evaluation of small peripheral nerve fiber function
Burel Goodin 332 8
Ethnicity and subjective sleep quality are interactively related to standard and situation-specific measures of pain catastrophizing
Carmen Green 124 242
The role of race and neighborhood socioeconomic status on pain persistence
Carmen Green 155 235
Factors related to the chronic cancer pain experience among cancer survivors
Yun Guan 210 239
A model combining in vivo electrophysiological and behavioral approaches to study mechanisms of spinal cord stimulation induced analgesia in spinal nerve injured rats
Jessica Guite 342 236
Adolescent and parent pain beliefs, readiness to change, and treatment expectations at an initial multidisciplinary pain clinic consultation
Steven Harte 208 229
Pregabalin modulates motivational but not sensory pain behaviors in rats with peripheral nerve injury
Barbara Hastie Paper 323/Poster 133 175
Examination of predictive models for surgical outcome and change over time
Linda Hatfield 127 307
Procedural pain management: Is there a potential to mitigate adult pain responsivity?
Linda Hatfield 301 306
Age dependency of sucrose analgesia during routine immunizations at 4 and 6 months of age
YING HE 199 284
Paclitaxel, at ultra low sub-apoptotic doses, induces substance P release via synchronized activation of PKA and PKC
Hamid Hekmat 320 17
Does Type D personality predict acute human pain reactions?
Chris Herndon 179 311
A stepwise approach to changing the landscape of pharmacist education on pain and palliative care: A report from the Strategic Planning Summit for the Advancement of Pain and Palliative Care Pharmacy
Adam Hirsh 175 52
Pain treatment in adults with cerebral palsy: cross-validation and extension
Andrew Ho 237 145
Acute efficacy of telcagepant in migraine patients with prior use of opioids
Mark Hollins 177 221
Hypervigilance and catastrophizing, but not temporal summation, are elevated in sickle cell disease
Joseph Holtman 228 148
Novel small molecule alpha9 alpha10 nicotinic receptor antagonists for pain management
Kathleen Holton 309 257
Preliminary results of a novel dietary intervention in Fibromyalgia patients with Irritable Bowel Syndrome
Constance Houck 122 83
Measurement of urinary substance P as an indicator of bladder hyperreactivity after ureteral reimplantation in children
Mark Jensen 107 115
Correlation of outcome measures and responder identification sensitivity in chronic low back pain: pooled analysis of 2 trials of etoricoxib
Catherine Johannes 129 209
Treatment seeking behavior of adults with chronic lower back pain and chronic osteoarthritis pain: descriptive results from a population survey
Kim Jones 103 113
Objective balance deficits in fibromyalgia patients are related to disease severity, cognition and body mass index
James Jones 243 137
Short-term tolerability and safety profile of a novel diclofenac potassium liquid filled capsule formulation
Kim Jones 262 279
Sodium oxybate improves function and quality of life in fibromyalgia -- results from a phase 3, randomized, controlled trial
Carla Jungquist 277 126
Sleep disordered breathing in patients taking opiates for chronic pain
Accepted Papers
Accepted Posters:
A - E F - J K - O P - T U - Z
Guidelines For Poster Presenters